Pharmaceuticals
The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know
more?
You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.
The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health.
Show Less
Read more
ICT budget forecasts in Medium-sized Italian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Medium-sized Italian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
ICT budget forecasts in Small Swiss Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Small Swiss Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
ICT budget forecasts in Large Italian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Large Italian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
ICT budget forecasts in Medium-sized Swiss Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Medium-sized Swiss Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
ICT budget forecasts in Large Swiss Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Large Swiss Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
ICT budget forecasts in Small Finnish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Small Finnish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
ICT budget forecasts in Medium-sized Finnish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Medium-sized Finnish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
2013 Drugs of Abuse Testing Market:US, Europe (France, Germany, Italy, Spain, UK), Japan (Datapack)
This new 318-page report contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market...
June
2013
EUR 4,207USD 5,500GBP 3,545AUD 5,853JPY 538,644SEK 36 419CHF 5'175CAD 5,719
ICT budget forecasts in Large Finnish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013
Synopsis
This report illustrates how Kable expects Large Finnish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services,...
June
2013
FROM
EUR 379USD 495GBP 319AUD 527JPY 48,478SEK 3 278CHF 466CAD 515
Brazil Pharmaceuticals and Healthcare Report Q3 2013
BMI View: The Brazilian government has become increasingly proactive in supporting local pharmaceutical industry. At a time when the public sector is trying to balance increasing demand for healthcare...
June
2013
EUR 961USD 1,257GBP 810AUD 1,337JPY 123,068SEK 8 321CHF 1'182CAD 1,307
Romanian Pharmaceutical Report - May 2013
Romania’s pharmaceutical market, measured at distribution price levels, expanded by 3 6% y/y (4 3% % y/y in local currency) to EUR 691 9mn (RON 3 1bn) in Q1/2013 Nonetheless, on a quarterly basis, the...
June
2013
FROM
EUR 225USD 210GBP 128AUD 306JPY 25,768SEK 1 812CHF 302CAD 281
Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals
Summary
Our “Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals”...
June
2013
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Drugs of Abuse Testing in France: Hospitals and Commercial Labs - 2013
This new 318-page report contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market...
June
2013
FROM
EUR 1,874USD 2,450GBP 1,579AUD 2,607JPY 239,942SEK 16 223CHF 2'305CAD 2,548
2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs
This new 269-page report provides a comprehensive analysis of the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares...
June
2013
FROM
EUR 2,103USD 2,750GBP 1,773AUD 2,926JPY 269,322SEK 18 210CHF 2'588CAD 2,859
2013 Endocrine Function Testing Market in Italy: Hospitals and Commercial Labs
This new 269-page report provides a comprehensive analysis of the Italian endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares...
June
2013
FROM
EUR 1,874USD 2,450GBP 1,579AUD 2,607JPY 239,942SEK 16 223CHF 2'305CAD 2,548
2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs
This new 269-page report provides a comprehensive analysis of the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares...
June
2013
FROM
EUR 1,874USD 2,450GBP 1,579AUD 2,607JPY 239,942SEK 16 223CHF 2'305CAD 2,548
2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices
This new 271-page report provides a comprehensive analysis in the German endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares...
June
2013
FROM
EUR 1,874USD 2,450GBP 1,579AUD 2,607JPY 239,942SEK 16 223CHF 2'305CAD 2,548
Analgesics in Taiwan
Over the review period, analgesics experienced stable growth because of consumer lifestyles. The busy, modern, fast pace of life causes headaches and other pain-related symptoms and drives product sales....
June
2013
FROM
EUR 688USD 900GBP 580AUD 958JPY 88,142SEK 5 959CHF 847CAD 936
Italy Pharmaceuticals and Healthcare Report Q3 2013
BMI View: The sharp drop in public pharmaceutical expenditure in Italy in 2012 to a level below that of 2001 does not bode well for drugmakers and pharmacies in the country. The success of the implemented...
June
2013
EUR 961USD 1,257GBP 810AUD 1,337JPY 123,068SEK 8 321CHF 1'182CAD 1,307
Kuwait Pharmaceuticals and Healthcare Report Q3 2013
BMI View: Opportunities in Kuwait's healthcare and pharmaceuticals market are limited, given its small population, limited domestic drug production and the high proportion of expatriates. The government...
June
2013
EUR 961USD 1,257GBP 810AUD 1,337JPY 123,068SEK 8 321CHF 1'182CAD 1,307
